Target intelligence / Profile preview

STIP1 homology and U-box containing protein 1 (STUB1)

Target
STUB1
Molecular classification
Enzyme (E3 ubiquitin ligase), Co-chaperone, Protein quality control factor, Ubiquitin-proteasome pathway component
01

Overview

STIP1 homology and U-box containing protein 1 (abbreviated as STUB1, commonly known as CHIP) is an E3 ubiquitin-protein ligase involved in the cellular protein quality control system. CHIP functions as a co-chaperone by binding to heat shock proteins (HSP70/HSC70/HSP90), inhibiting their ATPase activity, and channeling damaged, misfolded, or surplus proteins toward ubiquitin-mediated proteasomal degradation. Structurally, CHIP contains an N-terminal TPR (tetratricopeptide repeat) domain for chaperone interaction, a central coiled-coil domain, and a C-terminal U-box domain conferring E3 ligase enzymatic activity. STUB1/CHIP plays central roles in maintaining proteostasis, especially under stress, and regulates key processes such as autophagy, apoptosis, cell proliferation, and signal transduction by controlling the turnover of receptors and transcription factors. Mutations in STUB1 cause autosomal dominant spinocerebellar ataxia type 48 (SCA48) and recessive ataxia SCAR16 due to loss of CHIP function and impaired neuronal protein homeostasis. CHIP is linked to multiple neurodegenerative and neoplastic conditions and is of emerging interest as a therapeutic target and biomarker for diseases involving protein aggregation and dysregulated degradation.

Other names
E3 ubiquitin-protein ligase CHIPCHIP (C-terminus of HSC70-interacting protein)Carboxy-terminus of Hsp70-interacting proteinUBOX1HSPABP2NY-CO-7PP1131SDCCAG7Antigen NY-CO-7CLL-associated antigen KW-8Serologically defined colon cancer antigen 7
02

Mechanism of action

Promotes ubiquitination and proteasomal degradation of misfolded, damaged, or excess client proteins (including tau, α-synuclein, p53, ErbB2, androgen receptor). E3 ligase activity depends on its U-box domain and interaction with E2 ubiquitin-conjugating enzymes.

03

Biological functions

Protein ubiquitinationProtein quality control/proteostasisRegulation of molecular chaperone activityApoptosisCell proliferationRegulation of signaling receptors (e.g., ErbB2, androgen receptor)Stress responseImmune regulation
04

Disease associations

Neurodegenerative disease (spinocerebellar ataxia types 16 and 48, other ataxias, tauopathies, polyglutamine disorders, α-synucleinopathies)Cancer (regulation of oncogenes and tumor suppressors)Inflammation/Immune dysregulation
05

Safety considerations

Potential risk of immune dysregulation if targeted therapeutically (CHIP regulates T-cell signaling and cytokine receptors)Disruption of proteostasis may result in unwanted accumulation or elimination of regulatory proteins, leading to toxicity, neurodegeneration, or impaired cell survivalOff-target effects due to CHIP’s interaction with many cellular proteins
06

Interacting drugs

None specifically approved as direct STUB1/CHIP modulators; some small molecules in preclinical development or tool compounds but none widely established in clinical use.
07

Biomarkers

Mutations in STUB1 gene (diagnostic for spinocerebellar ataxia types 16 and 48)Aggregate accumulation (e.g., tau, α-synuclein) in neurodegeneration as indirect markersReduced or altered CHIP protein function can be a biomarker in cerebellar ataxias or impaired proteostasis disorders

Beyond the preview

Go deeper on STIP1 homology and U-box containing protein 1 (STUB1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on STIP1 homology and U-box containing protein 1 (STUB1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call